Maekawa, Masato
Hamamatsu University · Hamamatsu University School of Medicine
4 papers on CoChatORCID 0000-0001-9710-5324
Most cited papers
- Verified
Comprehensive assessment of multiple tryptophan metabolites as potential biomarkers for immune checkpoint inhibitors in patients with non-small cell lung cancer
Karayama, M., Masuda, J., Mori, K., Yasui, H., Hozumi, H., Suzuki, Y., Furuhashi, K., Fujisawa, T., Enomoto, N., Nakamura, Y., et al. (2021) · Clinical and Translational Oncology
Cancer Immunotherapy and BiomarkersTryptophan and brain disorders
Cited by 84
- Verified
Plasma CCN2 (connective tissue growth factor; CTGF) is a potential biomarker in idiopathic pulmonary fibrosis (IPF)
Kono, M., Nakamura, Y., Suda, T., Kato, M., Kaida, Y., Hashimoto, D., Inui, N., Hamada, E., Miyazaki, O., Kurashita, S., et al. (2011) · Clinica Chimica Acta
Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisConnective Tissue Growth Factor Research
Cited by 79
- Verified
Prevalence of ischemic heart disease among patients with sleep apnea syndrome
MAEKAWA, M., SHIOMI, T., USUI, K., SASANABE, R., & KOBAYASHI, T. (1998) · Psychiatry and Clinical Neurosciences
Obstructive Sleep Apnea ResearchSleep and related disorders
Cited by 31
- Verified
Investigation of MDA-LDL (malondialdehyde-modified low-density lipoprotein) as a prognostic marker for coronary artery disease in patients with type 2 diabetes mellitus
Kotani, K., Tashiro, J., Yamazaki, K., Nakamura, Y., Miyazaki, A., Bujo, H., Saito, Y., Kanno, T., & Maekawa, M. (2015) · Clinica Chimica Acta
Antioxidant Activity and Oxidative StressDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 24
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free